- Filed
- May 11, 2020 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2020 · Mar 31, 2020 | 12.02M sh |
| Shares Diluted | Q1 2020 · Mar 31, 2019 | 12.47M sh |
| Capex | Q1 2020 · Mar 31, 2020 | $429K |
| Capex | Q1 2020 · Mar 31, 2019 | $109K |
| Operating Cash Flow | Q1 2020 · Mar 31, 2020 | −$11.24M |
| Operating Cash Flow | Q1 2020 · Mar 31, 2019 | −$5.74M |
| Long Term Debt | Q1 2020 · Mar 31, 2020 | $183.47M |
| Long Term Debt | Q1 2020 · Dec 31, 2019 | $167.95M |
| Cash And Equivalents | Q1 2020 · Mar 31, 2020 | $5.05M |
| Cash And Equivalents | Q1 2020 · Dec 31, 2019 | $3.77M |
| Stockholders Equity | Q1 2020 · Mar 31, 2020 | $72.47M |
| Stockholders Equity | Q1 2020 · Dec 31, 2019 | $101.5M |
| Current Liabilities | Q1 2020 · Mar 31, 2020 | $151.4M |
| Current Liabilities | Q1 2020 · Dec 31, 2019 | $160.74M |
| Total Liabilities | Q1 2020 · Mar 31, 2020 | $529.9M |
| Total Liabilities | Q1 2020 · Dec 31, 2019 | $511.88M |
| Current Assets | Q1 2020 · Mar 31, 2020 | $264.54M |
| Current Assets | Q1 2020 · Dec 31, 2019 | $272.4M |
| Total Assets | Q1 2020 · Mar 31, 2020 | $617.83M |
| Total Assets | Q1 2020 · Dec 31, 2019 | $651.86M |
| Eps Diluted | Q1 2020 · Mar 31, 2020 | −$3.68 |
| Eps Diluted | Q1 2020 · Mar 31, 2019 | $0.11 |
| Eps Basic | Q1 2020 · Mar 31, 2020 | −$3.68 |
| Eps Basic | Q1 2020 · Mar 31, 2019 | $0.12 |
| Sga Expense | Q1 2020 · Mar 31, 2020 | $27.95M |
| Sga Expense restated | Q1 2020 · Mar 31, 2019 | $15.6M |
| Net Income | Q1 2020 · Mar 31, 2020 | −$44.27M |
| Net Income | Q1 2020 · Mar 31, 2019 | $1.33M |
| Operating Income | Q1 2020 · Mar 31, 2020 | −$54.45M |
| Operating Income | Q1 2020 · Mar 31, 2019 | $5.34M |
| Gross Profit | Q1 2020 · Mar 31, 2020 | $6.69M |
| Revenue | Q1 2020 · Mar 31, 2020 | $71.56M |
| Revenue | Q1 2020 · Mar 31, 2019 | $87.33M |